# Vor Biopharma Inc.: Form SCHEDULE 13D/A, filed Mar 16, 2026

- Company: [Vor Biopharma Inc.](/companies/vor.md) (CIK 1817229)
- Form: SCHEDULE 13D/A
- Filed: 2026-03-16
- Accepted by EDGAR: Mar 16, 2026, 16:15 ET
- Period: not reported
- Accession: 0001104659-26-028470
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1817229/000110465926028470/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817229/000110465926028470/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817229/000110465926028470/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Mar 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-028470. Last ingested by Listed: Nov 4, 2026, 20:45 ET. No prices; not investment advice.